AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2018
Sep 28, 2018
33298_dirs_2018-09-28_7c3f1984-b07f-4a9c-b22d-35fee21c3318.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2018-09-26
Reporting Person: Bruzzese Anthony (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-09-26 | Common Stock, par value $0.01 | O | 40800 | $0.1 | Acquired | 1100561 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-09-26 | Option to purchase Common Stock | $0.10 | O | 40800 | Disposed | 2018-09-30 | Common Stock (40800) | Direct |
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17